Agro-Biotech News

Scientists from Henan University of Science and Technology and partners have developed a novel vaccine using CRISPR-Cas9-based gene editing to target hypervirulent Marek's disease virus (MDV), a major cause of economic losses in the poultry industry. The findings of the study, published in Poultry Science, highlight the growing challenge of emerging MDV strains that evade protection from existing commercial vaccines.